European Archives - Page 27 of 1165 - European Medical Journal

Efruxifermin Improves Fibrosis in Long-Term MASH Study

In this double-blind, placebo-controlled trial, 181 participants were randomised to receive weekly injections of either 28 mg or 50 mg of efruxifermin or a placebo.

Midlife Health Conditions Linked to Increased Cancer Risk

A new study of nearly 129,000 adults has revealed that common midlife comorbidities, such as respiratory and cardiovascular conditions, are associated with an increased risk of cancer and cancer-related death.

Candida Infection a Significant Risk Factor for Oesophageal Cancer in Achalasia

In patients with achalasia, esophageal Candida infection may be more than an incidental finding. A new study reveals it significantly increases the risk of developing esophageal cancer.

Syphilis and Drug-Resistant Gonorrhoea on the Rise

The UKHSA has released its annual STI data, with continuing concern over rising syphilis and drug-resistant gonorrhoea.

Global Rise in Skin Cancer Among Older Adults

A new global observational study has revealed a continued rise in skin cancer burden among older populations, particularly in high-income countries.

Radiotherapy After Prostate Surgery Causes Minimal Side Effects

This clinical trial evaluated the safety of stereotactic body radiotherapy to the prostate bed following radical prostatectomy.

PET/CT Refines Biopsy Strategy for Suspected Lung Cancer

New findings support the integration of PET/CT prior to biopsy in patients with intermediate-to-high-risk lung nodules.

Breast MRI Efficiency Boosted by AI Without Compromising Diagnosis

AI-guided breast MRI could halve scan times without missing cancers, offering new efficiency for screening programmes.

One-Third of Patients with Myeloma May Achieve Long-Term Survival

A new analysis of early total therapy clinical trials has revealed that up to one-third of patients with newly diagnosed multiple myeloma may achieve long-term survival.

ERA 2025: Immune Profiling of Checkpoint Inhibitor-Induced Nephritis Reveals Distinct Subtypes with Prognostic Value

Presented at ERA 2025, this multicentre study identifies three immune subtypes of checkpoint inhibitor–induced nephritis, linking them to clinical outcomes and treatment responses.